HIV-associated Kaposi sarcoma: improving care with ART and targeted treatment in EpKS
Official title: Project 2
Funded at Lsu Health Sciences Center · NIH-11623232 · Data updated 2026-11-12
A patient-facing program exploring how standard HIV treatment plus cancer care can help people with epidemic Kaposi sarcoma in sub-Saharan Africa.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Lsu Health Sciences Center NIH-funded |
| Lab location | 1 site (New Orleans, United States) |
| Project start | September 1, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $105,257 |
| NIH project number | 3U54CA277846-04S1 |
| Project ID | NIH-11623232 on NIH RePORTER |
Who could benefit from this research
✓Could help
People living with HIV and either diagnosed EpKS at various stages, especially those in sub-Saharan Africa receiving ART.
✕Less likely to help
Patients with KS not eligible for ART-based approaches or those not requiring KS-directed therapy may see no direct benefit.
What this research studies
This grant focuses onEpKS, a cancer linked to HIV that is common in sub-Saharan Africa. It builds on ACTG staging criteria to guide treatment decisions and compares outcomes for patients treated with antiretroviral therapy (ART) alone versus ART combined with chemotherapy. The project is designed to inform how best to manage KS across different disease stages and immune statuses. By examining treatment responses, it aims to improve survival and quality of life for people living with HIV and KS in the region.
Why it matters
Potential benefit: If successful, patients with EpKS could receive clearer, more effective treatment plans leading to better control of KS and improved health.
How similar studies have gone: Past work has shown variable responses to KS treatments, with ART sometimes controlling KS and chemotherapy helping more advanced cases; this study seeks to optimize those outcomes.
Where this research is happening
-
Lsu Health Sciences Center
New Orleans, United States Active
Researchers
- Principal investigator: Ngalamika, Owen — Lsu Health Sciences Center
- Study coordinator: Ngalamika, Owen
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.